Key clinical point: The ACA is associated with ovarian cancer diagnosis at earlier stages and with treatment within 30 days.
Major finding: Women with public insurance under the ACA had significant improvements in early-stage ovarian cancer diagnosis and treatment within 30 days (DD = 2.5% for each).
Study details: A study of National Cancer Database surveys from more than 130,000 women.
Disclosures: Dr. Smith reported having no disclosures.
Smith A et al. ASCO 2019. Abstract LBA5563.